HLB Life Science has ranked among the top searched stocks for 10 days in the past month.
As of 12:30 PM on the 25th, HLB Life Science is trading at 28,400 KRW, up 1.43% from the previous day. This marks a 61.36% increase compared to August 28. HLB Life Science is known as an engineering service company related to energy saving.
Today, foreigners have a tentative net sell of 164,899 shares. Over the past five days, individual investors have net sold 385,459 shares, while foreigners and institutions have net bought 381,863 shares and 12,416 shares, respectively.
On September 21, HLB Life Science became a market issue with a 21% increase following the Phase 3 clinical trial results of 'Rivoceranib.'


※ Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an article auto-generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
![Clutching a Stolen Dior Bag, Saying "I Hate Being Poor but Real"... The Grotesque Con of a "Human Knockoff" [Slate]](https://cwcontent.asiae.co.kr/asiaresize/183/2026021902243444107_1771435474.jpg)
